S10 Ep21: Bagley Summarizes the ACTION trial of ONC201 in H3 K27M–Mutant Diffuse Midline Gliomas

from OncLive® On Air · host OncLive® On Air

Dr Bagley discusses the evaluation of the small molecule ONC201 in the phase 3 ACTION trial in H3 K27M–mutant diffuse midline gliomas.

Episode metadata supplied by the publisher feed · Published Mar 21, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep21: Bagley Summarizes the ACTION trial of ONC201 in H3 K27M–Mutant Diffuse Midline Gliomas

0:00 13:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 13 minutes long.

This episode was published on March 21, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!